GLP 1 dosage for weight loss: titration schedules, dose ranges

Every GLP-1 drug for weight loss starts at a low dose and increases gradually over several months. This slow escalation is called titration. It exists because jumping straight to full dose causes severe nausea, vomiting, and other gastrointestinal side effects in most people. Your body needs time to adjust.

The dose you end up on also affects how much weight you lose. Higher doses produce more weight loss in clinical trials. But higher doses also cause more side effects. The goal is to find dose that gives you best results you can tolerate.

How does semaglutide dosing work for weight loss?

The FDA approved prescribing information for Wegovy lays out a five step titration schedule. You take one injection per week, on same day each week, and increase dose every four weeks.

The schedule looks like this. Weeks 1 through 4, you take 0.25 mg. Weeks 5 through 8, you move to 0.5 mg. Weeks 9 through 12, you go to 1.0 mg. Weeks 13 through 16, you take 1.7 mg. From week 17 onward, you're at maintenance dose of 2.4 mg.

That entire process takes about four to five months. During that time, weight loss is already happening, but it accelerates as dose increases. Most of appetite suppression kicks in around 1.0 mg to 1.7 mg range. By 2.4 mg, full effect is in place.

If you can't tolerate 2.4 mg, prescribing information allows a temporary drop back to 1.7 mg for up to four weeks. If 2.4 mg still isn't tolerable after that, your doctor may keep you at 1.7 mg as your maintenance dose. You'll still lose weight at 1.7 mg. It will just be less than at full dose.

Ozempic follows a similar pattern but tops out at 2.0 mg instead of 2.4 mg. Since Ozempic isn't approved for weight loss, there's no formal weight loss titration schedule. Doctors who prescribe it off label for weight management typically follow Wegovy schedule but stop one step earlier.

How does tirzepatide dosing work for weight loss?

Tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) follows a different titration path. You start at 2.5 mg weekly for at least four weeks. Then you increase by 2.5 mg every four weeks.

The available dose steps are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. The minimum maintenance dose is 5 mg. The maximum is 15 mg.

Not everyone needs to reach 15 mg. In clinical trials, people at 10 mg lost about 19.5% of their body weight. At 15 mg, it was about 22.5%. The difference between 10 mg and 15 mg is real but not as large as difference between 5 mg and 10 mg. So some patients and their doctors decide that 10 mg or 12.5 mg gives them good enough results with fewer side effects.

If you want full breakdown of each dose step and what it delivers, our tirzepatide dosage chart covers that in detail. And if you're wondering how to decide between staying at a mid range dose or pushing higher, our article on what dose of Zepbound is most effective walks through tradeoffs.

What about oral GLP 1 dosing?

Oral Wegovy (semaglutide 25 mg daily) follows its own titration. You start at 3 mg daily for first month, then go to 7 mg, then 14 mg, and finally 25 mg. Each step lasts at least four weeks.

The pill has to be taken on an empty stomach with no more than 4 ounces of water. You can't eat, drink, or take other medications for at least 30 minutes afterward. This timing matters because food and fluid in stomach reduce how much semaglutide gets absorbed.

Foundayo (orforglipron) is simpler. It comes in 6 mg, 12 mg, and 36 mg doses. You start at 1 mg daily and increase over several weeks. Unlike oral Wegovy, it doesn't have food or water restrictions. You can take it any time of day.

Does a higher dose always mean more weight loss?

Generally yes, but with diminishing returns. The biggest jump in weight loss happens when you move from starter dose to mid range. Going from mid range to maximum adds more weight loss, but increase is smaller.

For semaglutide, difference between 1.0 mg and 2.4 mg was about 5 percentage points of body weight in STEP trials. For tirzepatide, difference between 5 mg and 15 mg was about 7 percentage points. Those are meaningful gaps, but they come with a proportional increase in side effects.

About 5% to 10% of patients in clinical trials stopped treatment because of side effects, and most of those discontinuations happened during dose escalation. The most common reasons were nausea, vomiting, and diarrhea.

This is why dose escalation should always be guided by your doctor. Some people do best at a dose that's lower than maximum. If you're losing weight steadily and feel good at 10 mg of tirzepatide, there may be no reason to push to 15 mg.

What happens if you can't tolerate a dose increase?

Your doctor has several options. The most common approach is to stay at your current dose for an extra four weeks before trying increase again. Often, side effects that were too intense first time are manageable after your body has had more time to adjust.

If a dose increase still causes problems on second attempt, your doctor can keep you at lower dose as your maintenance dose. As long as you're losing weight and your health markers are improving, exact dose number matters less than how your body is responding.

In some cases, doctors prescribe anti nausea medication like ondansetron to help patients get through early days of a dose increase. Eating smaller meals, avoiding fatty or greasy food, and staying hydrated also help manage gastrointestinal effects.

Skipping a dose or taking a dose late is not dangerous, but it can affect how you feel. If you miss a dose and your next scheduled dose is more than two days away, take missed dose as soon as you remember. If it's less than two days away, just skip it and take your next dose on schedule. Don't double up.

How long do you stay on maintenance dose?

For as long as it's working. GLP 1 drugs for weight loss are approved for chronic, long term use. There is no set endpoint. The STEP 5 trial followed patients on semaglutide for two years and found that weight loss was maintained entire time.

When patients stop GLP 1 drugs, most regain a large portion of weight they lost. This is consistent across every trial that has studied discontinuation. The biological signals that drive appetite and fat storage return to baseline once drug is removed.

Some doctors are exploring whether a lower maintenance dose can preserve weight loss with fewer side effects and lower cost. For example, a patient who lost weight on tirzepatide 15 mg might step down to 10 mg or 7.5 mg for long term maintenance. Early data on this approach looks encouraging but isn't definitive yet. It's something to discuss with your provider based on how your body responds over time.

The dose that got you to your goal weight and dose that keeps you there don't have to be same.